Windlas Biotech Ltd

NSE:WINDLASHealthcare

₹906.10−1.23%At closeAt close · Mon 19 Oct · ≈ AED 35.01 · Market cap $199.37M

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	35.7%	34.6%	35.5%	36.3%	37.9%	18.1%	—	—
Operating margin	10.2%	8.7%	9.4%	10.4%	8.7%	8.2%	8.2%	+0.0 pts
Net margin	3.7%	8.2%	8.3%	9.3%	8.0%	7.4%	7.4%	+0.0 pts
EBITDA margin	8.5%	12.8%	13.7%	14.6%	14.8%	11.6%	—	—
Return on equity	8.0%	9.6%	10.6%	12.9%	12.1%	11.4%	11.4%	+0.0 pts
Return on assets	5.3%	7.8%	8.1%	9.3%	8.0%	7.3%	7.3%	+0.0 pts
Return on capital employed	21.4%	10.1%	11.8%	14.4%	12.9%	12.6%	—	—
Debt / equity	0.2×	0.0×	0.0×	0.0×	0.1×	0.1×	0.1×	+0.0%
Debt / assets	10.9%	1.4%	0.9%	0.6%	4.3%	3.9%	—	—
Interest coverage	33.7×	28.4×	60.8×	59.0×	15.1×	15.3×	—	—
Current ratio	2.1×	4.1×	2.9×	2.5×	2.1×	2.0×	2.0×	+0.0%
Quick ratio	1.6×	3.4×	2.3×	2.1×	1.8×	1.8×	—	—
Cash ratio	0.2×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Asset turnover	1.4×	0.9×	1.0×	1.0×	1.0×	1.0×	—	—
Inventory turnover	6.6×	5.2×	4.4×	6.4×	5.8×	12.0×	—	—
Receivables turnover	5.4×	4.2×	4.4×	4.6×	4.6×	4.0×	—	—
Dividend payout	0.0%	0.0%	17.9%	14.3%	18.8%	18.3%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.